Not to be missed: PROJECT CBD RELEASES EDUCATIONAL PRIMER ON CANNABINOID-DRUG INTERACTIONS
Given the increasing acceptance and prevalence of cannabis as a therapeutic option, it’s important for physicians and patients to understand how various cannabis components interact with commonly consumed pharmaceuticals.
BY ADRIAN DEVITT-LEE ON SEPTEMBER 25, 2018
Special Report Published by Project CBD
Project CBD, a California-based educational non-profit, has published an in-depth Primer on Cannabinoid-Drug Interactions for health professionals, patients, and public policy-makers. The 33-page report, summarized below, is available for free download at the bottom of the page.
Drug interactions are a significant consideration in modern medicine. More than half of U.S. adults regularly take prescription meds and at least 75 percent of Americans take at least one over-the-counter drug. Many people, including most seniors (the fastest growing demographic of cannabis users), take multiple drugs, and these compounds can interact and affect the metabolism of each other.
Cannabis is one of the most widely consumed substances in the United States and throughout the world, and a huge number of cannabis users also consume pharmaceutical products. Given the increasing acceptance and prevalence of cannabis as a therapeutic option, it’s important for physicians and patients to understand how various cannabis components, including cannabidiol (CBD)……………..
………………….cannabinoid therapies, which show promise for a wide range of conditions.
Project CBD hopes that “as cannabis therapeutics continues to gain acceptance among physicians and patients, adequate resources will become available for clinical studies involving drug interactions with CBD, THC and other plant cannabinoids.”
To download Project CBD’s Primer on Cannabinoid-Drug Interactions, click here.
For the full articles follow this link https://www.projectcbd.org/about/cannabis-pharmacology/project-cbd-releases-educational-primer-cannabinoid-drug-interactions